# Altis Labs funding rounds and investors

As of 13 Nov 2026, Altis Labs has raised $25M across 1 verified round on record, plus 1 round still being checked; latest: $25 million Series A led by OrbiMed and Qiming Venture Partners USA, announced 17 Sep 2026.

An AI platform for cancer trials

Website: http://www.altislabs.com  
Headquarters: Toronto  
Page: https://fireround.dev/companies/altis

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-17 | Series A | $25 million | OrbiMed, Qiming Venture Partners USA | Benchstrength, Cancer Breakthrough Fund, Fusion Fund, Innovation Endeavors | [altislabs.com](https://www.altislabs.com/news/altis-labs-raises-us-25-million-series-a-co-led-by-orbimed-and-qiming-venture-partners-usa-to-accelerate-clinical-development-with-ai-endpoints), [businesswire.com](https://www.businesswire.com/news/home/20260917703856/en/Altis-Labs-Raises-US%2425-Million-Series-A-Co-Led-by-OrbiMed-and-Qiming-Venture-Partners-USA-to-Accelerate-Clinical-Development-with-AI-Endpoints), [axios.com](https://www.axios.com/pro/biotech-deals/2026/09/17/altis-labs-series-a-ai-clinical-trial) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.